IP Library Granted Patent US 9,944,722
Granted Patent B2
US 9,944,722 · App. 13/701,074 · Granted Apr 17, 2018

Chelator and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,944,722
App. No.
13/701,074
Granted
Apr 17, 2018
Kind
B2
Abstract

The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity. The dimeric pentadentate chelator according to the invention has the following general formula: wherein Sc is a scaffold or a connecting structure that contains at least two functional groups enabling coupling of two pentadentate chelators (PD), and PD is a pentadentate chelator having the formula:

Claims (15)

1. A dimeric pentadentate chelator having the following general formula:

wherein PD is a pentadentate chelator having the formula:

wherein S p1 is 6-amino hexanoic acid;

wherein Sc is diethylenetriamine;

wherein an amine of S p1 is coupled to PD to form an amide bond; and

wherein a carboxyl of S p1 is coupled to a primary amine of Sc to form an amide bond.

2. The dimeric pentadentate chelator of claim 1 , further comprising a group Q and having the following general formula:

wherein Q is selected from a solid phase, a detection label, and a biomarker.

3. The dimeric pentadentate chelator of claim 2 , wherein Q is a solid phase comprising a natural or synthetic polymer.

4. The dimeric pentadentate chelator of claim 2 , wherein the solid phase is a porous chromatographic support.

5. The dimeric pentadentate chelator of claim 3 , wherein Q is made of a cross-linked carbohydrate material selected from the group consisting of agarose, agar, cellulose, dextran, chitosan, konjac, carrageenan, gellan and alginate.

6. The dimeric pentadentate chelator of claim 3 , wherein Q is made of synthetic polymers selected from the group consisting of styrene derivatives, divinylbenzene, acryl amides, acrylate esters, methacrylate esters, vinyl esters and vinyl amides.

7. The dimeric pentadentate chelator of claim 2 , wherein Q comprises magnetic particles.

8. The dimeric pentadentate chelator of claim 2 , wherein Q is a solid phase comprising a sensor surface.

9. The dimeric pentadentate chelator of claim 5 , wherein Q is made of agarose.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2012
From: ALGOTSSON, MATTIAS; ANDERSSON, LARS C.; BREKKAN, EGGERT; HEDEMYR, LEE; MALOISEL, JEAN-LUC; PALMGREN, RONNIE
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 029379/0934 →